Top Biotechnology & Medical Research stocks in Hong Kong
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
2269WuXi Biologics (Cayman) | HK$44.94bn | 12.85 | n/a |
9926Akeso | HK$34.85bn | 15.45 | n/a |
6990Sichuan Kelun-Biotech Biopharmaceutical Co | HK$33.14bn | n/a | n/a |
1548Genscript Biotech | HK$27.83bn | n/a | n/a |
2162Keymed Biosciences | HK$8.97bn | n/a | n/a |
6855Ascentage Pharma International | HK$8.90bn | n/a | n/a |
2157Lepu Biopharma Co | HK$4.99bn | n/a | n/a |
1541ImmuneOnco Biopharmaceuticals Shanghai | HK$4.86bn | n/a | n/a |
2509Qyuns Therapeutics Co | HK$4.39bn | n/a | n/a |
2315Biocytogen Pharmaceuticals Beijing Co | HK$2.96bn | n/a | n/a |
2171CARsgen Therapeutics Holdings | HK$2.61bn | n/a | n/a |
9966Alphamab Oncology | HK$2.15bn | n/a | n/a |
2256Abbisko Cayman | HK$2.13bn | n/a | n/a |
6978Immunotech Biopharm | HK$1.70bn | n/a | n/a |
2105Laekna | HK$1.68bn | n/a | n/a |
1875TOT Biopharm International Co | HK$1.65bn | n/a | n/a |
1521Frontage Holdings | HK$1.57bn | 16.71 | n/a |
2616CStone Pharmaceuticals | HK$1.57bn | n/a | n/a |
2181Mabpharm | HK$1.48bn | n/a | n/a |
2496Wuhan YZY Biopharma Co | HK$1.45bn | n/a | n/a |